Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valrubicin cream 1% vs vehicle and Daivonex in plaque psoriasis (intra-individual, left/right)
2010-023789-33Phase 2Completed
- Sponsor
- ValDerm
- Start
- Dec 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in plaque psoriasis comparing Valrubicin vs vehicle (intra-individual) with Valrubicin vs Daivonex (calcipotriol) (intra-individual) (2 arms). Primary endpoints: Primary antipsoriatic efficacy of Valrubicin cream 1% vs vehicle, Comparative efficacy of Valrubicin cream 1% vs Daivonex (calcipotriol) cream and 1 more. Started Dec 2010; status: completed.
02
Drugs
valrubicin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2010-023789-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023789-33.